Kimberly Kamp

Kimberly Kamp is a Researcher at Erasmus MC, Department of Gastroenterology & Hepatology, Erasmus University Rotterdam. Her research focuses on neuroendocrine tumors, particularly pancreatic and gastroenteropancreatic variants, with emphasis on hormonal mechanisms, genetic mutations, and treatment strategies. She investigates how hormone secretory syndromes influence tumor prognosis and explores novel therapeutic combinations for treatment-resistant tumors.

Research Interests:

• Molecular mechanisms in neuroendocrine tumors
• Genetic mutations (e.g., DAXX, PTCH2, CYFIP2)
• Hormone secretion pathways (serotonin, insulin-like growth factors)
• Pharmacological interventions (somatostatin analogs, dopamine agonists)
• Clinical outcomes and treatment resistance

Article Trends: Her work bridges molecular biology, oncology, and clinical pharmacology. Key themes include genetic profiling of tumors, biomarker discovery for prognosis, and drug efficacy studies for advanced neuroendocrine neoplasms.

Grants/Advising: No specific grants or advising roles explicitly mentioned.

Labs/Teams: Collaborates within the Erasmus MC research network on neuroendocrine tumor studies, but no dedicated lab/team name provided.